Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Labskin contract

4 Oct 2022 07:00

RNS Number : 5975B
Deepverge PLC
04 October 2022
 

 

4 October 2022

 

DeepVerge PLC

 

("DeepVerge" or "the Company")

 

 

Labskin contract to develop revolutionary new approach to testing for radiation exposure

 

Collaboration with team of experts to develop new standards to protect military and civilians working or living near radiation sources

 

Labskin, a DeepVerge (AIM:DVRG) business, announces its selection by the Intelligence Advanced Research Projects Activity ("IARPA"), part of the US Office of the Director of National Intelligence, to join a team of experts to develop new ways to evaluate radiation exposure in civilians and military personnel. 

 

Labskin is a key member of a consortium selected to develop these technologies in collaboration with a multidisciplinary team of experts including professors from the University of Columbia in New York, Georgetown University in Washington DC, the Georgia Institute of Technology, scientists from the American Type Culture Collection ("ATCC") and computer scientists and researchers from ARETE Associates, a defence contractor specialising in sensing solution and machine learning algorithms.

 

In a 3-year project worth $810k to the Company, starting immediately, Labskin will help develop this technology into minimally invasive testing for radiation for a programme known as Targeted Evaluation of Ionizing Radiation Exposure ("TEI-REX"). TEI-REX aims to develop novel approaches to evaluate organisms exposed to low-dose ionising radiation. Labskin, coupled with Skin Trust Club's expertise in skin research and microbiology, is essential for the project.

 

The goal of the project is to develop a new biodosimetry standard which could be applied to maintain the safety of military and civilian populations working or living in close proximity to ionizing radiation sources, such as: nuclear plants, nuclear vessels, ammunition, etc. Labskin's contribution is the creation of a simple non-invasive swab test to collect signatures from the skin surface that allows machine learning algorithms to detect and quantify the impact of any amount of radiation exposure on the skin microbiome.

 

David Caballero-Lima, Chief Scientist, Labskin commented:

"This is a unique opportunity to revolutionise the way we test for radiation exposure. Labskin and Skin Trust Club are at the forefront of an increasing number of cutting edge technologies that are changing our world. This technique can also be applied to detect the impact of pollution or a variety of chemicals on the environment. This type of testing could also be used to detect exposure in complex ecological systems such as the soil, crops or sediments."

 

Colin O'Sullivan, Chief Information Officer, Labskin commented:

"We are committed to the success of this very exciting project. The inclusion of artificial intelligence and the opportunity to work with ARETE Associates, with their vast experience in complex AI applications, will result in further advances in how AI can be used in conjunction with our skin model at scale. This project coincides with the expansion of our US labs in Delaware, which will assist in the implementation of this large project. We believe our proven ability to transition technology to the field with Skin Trust Club will be invaluable as we progress this project."

 

DeepVerge plc

Gerard Brandon, CEO

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

 

About DeepVerge

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, viruses and toxins. Utilizing artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

 

Labskin (Life Science Division)

Labskin have been pioneering the development of laboratory grown human skin platform for more than 15 years and is the only commercially available lab-grown full thickness human skin model that naturally mimics the skin's microbiome. With top 20 global consumer health and skincare clients, thousands of industry tests, the good and bad bacteria that naturally exists on human skin is present on Labskin when testing skin care, cosmetics, health care, drug delivery or wound care products. The Labskin test platform and protocols help clients maintain an optimum real-world environment, when testing their new ingredients and existing skincare products, that shows the positive or negative impact on skin's natural microflora.

 

Skin Trust Club

Skin Trust Club (www.skintrustclub.com), launched in 2021, provides customized skincare routines derived from a home test kit, lab tested and linked to local environment via a free smartphone App that updates in real-time and identifies skincare products that suit the subscribers unique skin microbiome. This revolutionizes how you take care of your skin with your own skincare routine. The Home Test Kit comprises a single swab that maps the skin microbiome delivering a report that produces the most appropriate daily skincare routine based on science, not guesswork. Using real-time air pollution and weather data from the customer's location, the Skin Trust App builds a complete picture of the skin microbiome and the impact of local surroundings.

 

About Reach announcements

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEADEDEAPAFFA
Date   Source Headline
21st Oct 20217:00 amRNS2nd Generation Microtox® PD equipment shipping
15th Oct 20217:00 amRNSRelated Party Transaction
6th Oct 20217:00 amRNSDVRG engages with Media.Monks re Skin Trust Club
20th Sep 20217:00 amRNSSponsor at Reuters Conference on Climate Change
15th Sep 20217:01 amRNSIndia Centre of Excellence for Modern Water AMBC
15th Sep 20217:00 amRNSInterim Results
3rd Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Aug 20217:00 amRNSContinued progress thru' Microsaic collaboration
26th Jul 202112:25 pmRNSResult of AGM
26th Jul 20217:00 amRNSUpdate
12th Jul 20217:00 amRNSAppointment of Group Marketing Officer
7th Jul 20211:16 pmRNSExercise of Options and Total Voting Rights
30th Jun 20215:28 pmRNSNotice of AGM
30th Jun 20215:28 pmRNSFinal Results
25th Jun 20212:55 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSMicrotox Successful Phase 3 Field Trials
23rd Jun 20211:15 pmRNSResult of General Meeting
7th Jun 202112:23 pmRNS£10m Firm /Cond'l Placings & Subs - replacement
7th Jun 20219:35 amRNSFirm & Cond'l Placings & Subscription for £10m
6th May 20217:00 amRNSNew AI centre of excellence in Cork
30th Apr 20215:25 pmRNSExercise of Warrants and Total Voting Rights
30th Apr 20217:00 amRNSExercise of Warrants and Total Voting Rights
28th Apr 20217:00 amRNSDeepVerge signs MoU for JV with China Resources
26th Apr 20217:00 amRNSSkin Trust Club iOS App goes live
22nd Apr 20212:05 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:01 pmRNSPrice Monitoring Extension
21st Apr 20213:00 pmRNSExercise of Warrants and Total Voting Rights
13th Apr 20212:34 pmRNSExercise of Warrants and Total Voting Rights
13th Apr 20217:00 amRNSDirector/PDMR Shareholding
7th Apr 20213:43 pmRNSExercise of Options and Total Voting Rights
31st Mar 20217:00 amRNSUpdates on Labskin, Modern Water, Skin Trust Club
25th Mar 20213:43 pmRNSDeepVerge Investor Presentation
24th Mar 20213:37 pmRNSExercise of Warrants and Total Voting Rights
24th Mar 20212:05 pmRNSSecond Price Monitoring Extn
24th Mar 20212:00 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNS3 year Technology & Comm'l Agreem't with Microsaic
23rd Mar 20219:48 amRNSExercise of Warrants and Total Voting Rights
17th Mar 20214:22 pmRNSExercise of Warrants and Total Voting Rights
17th Mar 20217:00 amRNSMicrotox® BT Eval'n of SARS-CoV-2 from breath test
12th Mar 202111:23 amRNSAward Nomination in China
8th Mar 20214:35 pmRNSPrice Monitoring Extension
8th Mar 20217:00 amRNSChange of interests of significant shareholder
5th Mar 20213:05 pmRNSExercise of Warrants and Total Voting Rights
2nd Mar 20217:00 amRNSEcowaterOS and Microtox PD Event in China
26th Feb 202112:11 pmRNSExercise of Warrants and Total Voting Rights
17th Feb 20217:00 amRNSProd'n orders worth $5m for Modern Water Equipment
15th Feb 20217:00 amRNSProposed Framework Services Ag'ment with Microsaic
10th Feb 20217:00 amRNSDeepverge adds two virus containment laboratories
8th Feb 20217:00 amRNSDirector/PDMR Shareholding
1st Feb 20215:45 pmRNSExercise of Warrants and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.